Medical Devices

Prototype of non-invasive method to measure hematocrit is complete

Published in Blood Weekly, November 24th, 2005

InMedica Development Corp. (IMDD), of Salt Lake City, Utah announced that Wescor, Inc., of Logan, Utah has completed the prototype of the CritPoint Non-Invasive Hematocrit Device.

The Directors of MicroCor, a subsidiary of InMedica, have accepted the prototype as complying with the condition of phase I of the Joint Development Agreement between the companies and have agreed to issue 500,000 new shares of MicroCor common stock to Wescor in consideration for their work on this phase of the project.

Wescor has started work on phase II of the project, which includes engineering testing, production of additional prototypes, as well as clinical trials, as...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2005-11-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry